CVRx (CVRX) Cash from Investing Activities (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.41% |
| Dec 31, 2025 | 76.95% |
| Sep 30, 2025 | -186.41% |
| Jun 30, 2025 | 9.65% |
| Mar 31, 2025 | -119.23% |
| Dec 31, 2024 | -40.54% |
| Sep 30, 2024 | 89.58% |
| Jun 30, 2024 | 61.29% |
| Mar 31, 2024 | -442.60% |
| Dec 31, 2023 | -333.33% |
| Sep 30, 2023 | 72.73% |
| Jun 30, 2023 | 40.42% |
| Mar 31, 2023 | -203.80% |
| Dec 31, 2022 | 70.08% |
| Sep 30, 2022 | -438.78% |
| Jun 30, 2022 | 83.28% |
| Mar 31, 2022 | 45.54% |
| Dec 31, 2021 | -226.06% |
| Sep 30, 2021 | 56.46% |
| Jun 30, 2021 | -275.25% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 14.41% |